UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
'Korea not at a point to raise social distancing level'
Despite sporadic cluster infections stemming from religious meetings and ot...
by Lee Han-soo
|
2020-06-30 14:22
라인
KPBMA to expand local drugmakers’ exchanges with Europe
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) s...
by Kim Chan hyuk
|
2020-06-30 14:09
라인
Bukwang to change clinical design for Covid-19 drug candidate
Bukwang Pharm said it would modify the clinical trial design on Levovir (cl...
by Kim Chan-hyuk
|
2020-06-30 13:18
라인
PTSD patients increased 45 percent in 5 years
According to the National Health Insurance Service, the number of post-trau...
by Shim Hyun-tai
|
2020-06-29 18:23
라인
‘Korean dendranthema extract improves knee health’
GC Wellbeing confirmed that its Siberian chrysanthemum extract, GCWB106, im...
by Shim Hyun-tai
|
2020-06-29 18:22
라인
AMC suggests new excision guideline for gastric cancer
A research team at Asan Medical Center (AMC) said Monday that in conducting...
by Lee Han-soo
|
2020-06-29 16:20
라인
‘Government should lower prices of generic drugs’
“Our policy should aim at reaching the OECD average of general drug use, ad...
by Kim chan-hyuk
|
2020-06-29 16:17
라인
KNUH releases clinical courses of 632 Covid-19 patients
Kyungpook National University Hospital has released the clinical courses of...
by Shim Hyun-tai
|
2020-06-29 16:08
라인
Samsung Bioepis’ drug to join bevacizumab biosimilar competition in Europe
Samsung Bioepis’ Aybintio is expected to heat up biosimilars competition re...
by Kim Chan hyuk
|
2020-06-29 16:08
라인
[From the Scene] Doctors 'brave' Covid-19, sizzling heat to thwart insurance benefit for herb medicine
Around a hundred physicians from across the nation gathered in central Seou...
by Choi Gwang-seok
|
2020-06-29 14:02
라인
Korea shifts gear toward long-term fight against Covid-19
The government has decided to adopt a new social distancing scheme as it pr...
by Lee Han-soo
|
2020-06-29 12:55
라인
Vivozon to start P3b trial of nonnarcotic analgesics in US
Vivozon said that it has started recruiting patients for phase 3b clinical ...
by Lee Han-soo
|
2020-06-26 17:13
라인
Korea conducting 15 coronavirus-related clinical trials
The Ministry of Food and Drug Safety says Korea is now conducting 15 corona...
by Shim Hyun-tai
|
2020-06-26 16:39
라인
Helixmith pushes ahead with P3-2 trial for neuropathic pain treatment
Helixmith said that it has started its phase 3-2 trial for its gene therapy...
by Lee Han-soo
|
2020-06-26 16:38
라인
Pharmaceutical goods lead healthcare exports in May
Korea’s exports of products in the healthcare sector grew 34.5 percent on-y...
by Kim chan-hyuk
|
2020-06-26 15:27
라인
Celltrion tops pharmaceutical brand reputation in June
Celltrion ranked the first in the local brand reputation of listed pharmace...
by Park Gi-taek
|
2020-06-26 15:23
라인
10 more Korean drugmakers nestle in Boston to enter US market
Ten Korean pharmaceutical companies have additionally settled in the Cambri...
by Kim chan-hyuk
|
2020-06-26 14:12
라인
Hanmi’s glucagon analog designated as drug for rare disease in children
Hanmi Pharmaceutical’s HM15136 (LAPS Glucagon Analog) has been designated a...
by Shim Hyun-tai
|
2020-06-26 14:06
라인
Government to disclose clinical information of 5,500 Covid-19 patients
The government will open the clinical information of over 5,500 patients di...
by Kwak Sung-sun
|
2020-06-26 13:10
라인
Small gatherings, hobby clubs new sources of cluster infections
Korea's new virus cases kept seesawing on Thursday, as small gatherings...
by Lee Han-soo
|
2020-06-26 11:53
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top